gene editing

Geneva, Switzerland — September 2026 Alcon announced the commercial launch of UNITY® M, a premium ophthalmic surgical microscope designed...

Cambridge, Massachusetts — September 3, 2026 eGenesis announced an important clinical update from its ongoing Expanded Access study of...

Zug, Switzerland & Boston, Mass. – August 28, 2026 CRISPR Therapeutics presented new Phase 1a durability data for CTX310,...

Philadelphia – August 27, 2026 iECURE, Inc. presented updated clinical data from the ongoing OTC-HOPE Phase 1/2 trial of...

Philadelphia, August 20, 2026 iECURE announced that updated clinical data from the ongoing OTC-HOPE trial of ECUR-506 in infants...

VELIZY-VILLACOUBLAY, France, July 23, 2026 Dassault Systèmes has expanded its 3DEXPERIENCE AI-native agentic platform with the launch of three...

NEW YORK, N.Y., July 23, 2026 Apertura Gene Therapy has announced its participation in a consortium selected to receive...

CAMBRIDGE, Mass., July 23, 2026 Prime Medicine (Nasdaq: PRME) announced that the U.S. Food and Drug Administration (FDA) has...

BAR HARBOR, Maine, USA, July 9, 2026 The Jackson Laboratory (JAX), in collaboration with the Broad Institute and a...

PHILADELPHIA, Pennsylvania, USA, July 9, 2026 GEMMA Biotherapeutics (GEMMABio) has been awarded funding from the Advanced Research Projects Agency...